Keyword: North Carolina

With momentum building in Pfizer’s gene therapy programs, it has bought a building in North Carolina where it will consolidate clinical manufacturing.

Precision BioSciences says it will have a manufacturing facility for its off-the-shelf CAR-T therapies up and running in the fourth quarter.

KriGen Pharmaceuticals plans to build a $7 million facility in Lillington, North Carolina.

Within two years, Novo says it will power it entire production network with solar, wind or water power.

With two-thirds of its customers in the U.S., Sterling Pharma Solutions decided to buy a facility there.

Seqirus plans to add cell-based and adjuvanted flu vaccine capacity in a $140 million expansion to its plant in Holly Springs, North Carolina.

U.K.-based CDMO Almac is adding to its U.S. operations with a new building at its site in North Carolina where it says it will house 100 new employees.

CSL's flu vaccine unit Seqirus posted $1.09 billion in sales during its 2018 fiscal year and turned in its first-ever profit.

North Carolina-based drug manufacturer Panaceutics said it will invest $5.8 million in a facility in Pittsylvania County, Virginia.